Cheng W - Search Results

1

Evaluation of a tumor electric field treatment system in a rat model of glioma.

Wu H, Wang C, Liu J, Zhou D, Chen D, Liu Z, Wu A, Yang L, Chang J, Luo C, Cheng W, Shen S, Bai Y, Mu X, Li C, Wang Z, Chen L. Wu H, et al. Among authors: cheng w. CNS Neurosci Ther. 2020 Nov;26(11):1168-1177. doi: 10.1111/cns.13441. Epub 2020 Jul 30. CNS Neurosci Ther. 2020. PMID: 32734621 Free PMC article.

2

HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation.

Cheng W, Li M, Cai J, Wang K, Zhang C, Bao Z, Liu Y, Wu A. Cheng W, et al. J Neurooncol. 2015 Apr;122(2):303-12. doi: 10.1007/s11060-014-1709-6. Epub 2015 Jan 4. J Neurooncol. 2015. PMID: 25557107 Free PMC article.

3

A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.

Cheng W, Ren X, Cai J, Zhang C, Li M, Wang K, Liu Y, Han S, Wu A. Cheng W, et al. Oncotarget. 2015 Oct 6;6(30):29285-95. doi: 10.18632/oncotarget.4978. Oncotarget. 2015. PMID: 26320189 Free PMC article.

4

Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.

Cheng W, Li M, Jiang Y, Zhang C, Cai J, Wang K, Wu A. Cheng W, et al. J Neurosurg. 2016 Jul;125(1):7-16. doi: 10.3171/2015.5.JNS142437. Epub 2015 Nov 6. J Neurosurg. 2016. PMID: 26544773

5

Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.

Cheng W, Zhang C, Ren X, Jiang Y, Han S, Liu Y, Cai J, Li M, Wang K, Liu Y, Hu H, Li Q, Yang P, Bao Z, Wu A. Cheng W, et al. J Neurosurg. 2017 Jan;126(1):249-259. doi: 10.3171/2015.11.JNS15432. Epub 2016 Mar 11. J Neurosurg. 2017. PMID: 26967788

6

Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.

Cheng W, Ren X, Zhang C, Cai J, Liu Y, Han S, Wu A. Cheng W, et al. Neurology. 2016 Jun 14;86(24):2226-34. doi: 10.1212/WNL.0000000000002770. Epub 2016 May 25. Neurology. 2016. PMID: 27225222

7

Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.

Cheng W, Ren X, Zhang C, Cai J, Han S, Wu A. Cheng W, et al. Mol Neurobiol. 2017 Oct;54(8):5996-6005. doi: 10.1007/s12035-016-0150-6. Epub 2016 Sep 30. Mol Neurobiol. 2017. PMID: 27696222

8

Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status.

Cheng W, Ren X, Zhang C, Han S, Wu A. Cheng W, et al. J Neurooncol. 2017 Apr;132(2):207-218. doi: 10.1007/s11060-016-2368-6. Epub 2017 Jan 16. J Neurooncol. 2017. PMID: 28091987

9

Treatment strategy and IDH status improve nomogram validity in newly diagnosed GBM patients.

Cheng W, Zhang C, Ren X, Wang Z, Liu X, Han S, Wu A. Cheng W, et al. Neuro Oncol. 2017 May 1;19(5):736-738. doi: 10.1093/neuonc/nox012. Neuro Oncol. 2017. PMID: 28339964 Free PMC article. No abstract available.

10

Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.

Han S, Meng L, Jiang Y, Cheng W, Tie X, Xia J, Wu A. Han S, et al. Among authors: cheng w. Br J Cancer. 2017 May 9;116(10):1302-1311. doi: 10.1038/bjc.2017.89. Epub 2017 Mar 30. Br J Cancer. 2017. PMID: 28359080 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,937 results

Search Page

Filters